Incidentaloma CT scan: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
[Location] CT scan may be helpful in the diagnosis of [disease name]. Differentiation between [[benign]] and [[malignant]] incidentaloma is important. [[Malignancy]] is suggested on CT by a large diameter more than 6 cms, irregular border, inhomogeneity, a “washout” of contrast after 15 min of less than 40%, and calcifications. Contrast-enhanced washout [[Computed tomography|CT]] utilizes the unique perfusion pattern of [[adenomas]]. [[Adenomas]] take up intravenous [[Computed tomography|CT]] contrast rapidly, but also have a rapid loss of contrast – a phenomenon termed ‘[[contrast]] enhancement washout’. It is assumed that [[malignant]] [[Adrenal gland|adrenal]] lesions usually enhance rapidly but demonstrate a slower washout of contrast medium.


==CT scan==
==CT scan==
*On CT scanning, differentiating between benign and malignant incidentaloma is important. Malignancy is suggested on CT by a large diameter more than 6 cms, irregular border, inhomogeneity, a “washout” of contrast after 15 min of less than 40%, and calcifications.<ref name="pmid19011181">{{cite journal| author=Boland GW, Blake MA, Hahn PF, Mayo-Smith WW| title=Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. | journal=Radiology | year= 2008 | volume= 249 | issue= 3 | pages= 756-75 | pmid=19011181 | doi=10.1148/radiol.2493070976 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19011181  }}</ref>
*On CT scanning, differentiation between [[benign]] and [[malignant]] incidentaloma is important. [[Malignancy]] is suggested on CT by a large diameter more than 6 cms, irregular border, inhomogeneity, a “washout” of contrast after 15 min of less than 40%, and calcifications.<ref name="pmid19011181">{{cite journal| author=Boland GW, Blake MA, Hahn PF, Mayo-Smith WW| title=Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. | journal=Radiology | year= 2008 | volume= 249 | issue= 3 | pages= 756-75 | pmid=19011181 | doi=10.1148/radiol.2493070976 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19011181  }}</ref>
*However, many malignant lesions look benign. A large diameter is not diagnostic; only about 25%of masses larger than 4 cm were adrenal cancer.
*However, many malignant lesions look benign. A large diameter is not diagnostic; only about 25% of masses larger than 4 cm were [[Adrenal gland|adrenal]] cancer.


=== The '''Hounsfield unit differentiation''' ===
=== The '''[[Hounsfield units|Hounsfield unit]] differentiation''' ===
* CT has a high spatial and quantitative contrast resolution, which allows assessment of tissue density by measuring X-ray absorption of tissues. This allows calculation of tissue attenuation or tissue density values, which are measured in Hounsfield units (HU).
* [[Computed tomography|CT]] has a high quantitative contrast resolution, which allows assessment of tissue density by measuring [[X-ray]] absorption of tissues.  
* This allows calculation of tissue attenuation or tissue density values, which are measured in [[Hounsfield units]] (HU).


* The '''Hounsfield unit (HU)''' is a quantity commonly used in computed tomography (CT) scanning to express CT numbers in a standardized and convenient form.  
* The '''[[Hounsfield units|Hounsfield unit]] (HU)''' is a quantity commonly used in [[computed tomography]] (CT) scanning to express [[Computed tomography|CT]] numbers in a standardized and convenient form.  
* Hounsfield units are obtained from a linear transformation of the measured attenuation coefficients.  
* Hounsfield units are obtained from a linear transformation of the measured attenuation coefficients.  


* The intracytoplasmic fat in adenomas results in low attenuation on nonenhanced CT in contrast to nonadenomas have higher attenuation in nonenhanced CT.<ref name="pmid20823463">{{cite journal| author=Nieman LK| title=Approach to the patient with an adrenal incidentaloma. | journal=J Clin Endocrinol Metab | year= 2010 | volume= 95 | issue= 9 | pages= 4106-13 | pmid=20823463 | doi=10.1210/jc.2010-0457 | pmc=2936073 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20823463  }}</ref>
* The intracytoplasmic [[fat]] in [[adenomas]] results in low attenuation on nonenhanced [[Computed tomography|CT]] in contrast to nonadenomas have higher attenuation in nonenhanced CT.<ref name="pmid20823463">{{cite journal| author=Nieman LK| title=Approach to the patient with an adrenal incidentaloma. | journal=J Clin Endocrinol Metab | year= 2010 | volume= 95 | issue= 9 | pages= 4106-13 | pmid=20823463 | doi=10.1210/jc.2010-0457 | pmc=2936073 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20823463  }}</ref>


* Typical precontrast Hounsfield unit (HU) values are adipose tissue = -20 to -150 HU and kidney = 20 to 150 HU.  
* Typical pre-contrast [[Hounsfield units|Hounsfield unit]] (HU) values are [[adipose tissue]] = -20 to -150 HU and [[kidney]] = 20 to 150 HU.  


* If an adrenal mass measures <10 HU on unenhanced CT, the likelihood that it is a benign adenoma is nearly 100 percent.  
* If an [[Adrenal mass causes|adrenal mass]] measures <10 HU on unenhanced [[Computed tomography|CT]], the likelihood that it is a [[benign]] [[adenoma]] is nearly 100 percent.  


* Up to 30 percent of adenomas do not contain large amounts of lipid.
* Up to 30 percent of [[adenomas]] do not contain large amounts of [[lipid]].


* A homogeneous adrenal mass with a smooth border and an attenuation value <10 HU on unenhanced CT is likely to be a benign adenoma.<ref name="pmid12614096">{{cite journal| author=Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA et al.| title=Management of the clinically inapparent adrenal mass ("incidentaloma"). | journal=Ann Intern Med | year= 2003 | volume= 138 | issue= 5 | pages= 424-9 | pmid=12614096 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12614096  }}</ref>
* A homogeneous [[Adrenal gland|adrenal]] mass with a smooth border and an attenuation value <10 HU on unenhanced CT is likely to be a [[benign]] [[adenoma]].<ref name="pmid12614096">{{cite journal| author=Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA et al.| title=Management of the clinically inapparent adrenal mass ("incidentaloma"). | journal=Ann Intern Med | year= 2003 | volume= 138 | issue= 5 | pages= 424-9 | pmid=12614096 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12614096  }}</ref>


* The only patients in the nonadenoma groups with a noncontrast CT HU <10 were those with myelolipomas.  
* The only patients in the nonadenoma groups with a noncontrast CT HU <10 were those with [[Myelolipoma|myelolipomas]].  


=== Contrast-enhanced washout CT ===
=== Contrast-enhanced washout CT ===
*Contrast-enhanced washout CT utilizes the unique perfusion pattern of adenomas. Adenomas take up intravenous CT contrast rapidly, but also have a rapid loss of contrast – a phenomenon termed ‘contrast enhancement washout’.<ref name="pmid11110946">{{cite journal| author=Peña CS, Boland GW, Hahn PF, Lee MJ, Mueller PR| title=Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. | journal=Radiology | year= 2000 | volume= 217 | issue= 3 | pages= 798-802 | pmid=11110946 | doi=10.1148/radiology.217.3.r00dc29798 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11110946  }}</ref>
*Contrast-enhanced washout [[Computed tomography|CT]] utilizes the unique perfusion pattern of [[adenomas]]. [[Adenomas]] take up intravenous [[Computed tomography|CT]] contrast rapidly, but also have a rapid loss of contrast – a phenomenon termed ‘[[contrast]] enhancement washout’.<ref name="pmid11110946">{{cite journal| author=Peña CS, Boland GW, Hahn PF, Lee MJ, Mueller PR| title=Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. | journal=Radiology | year= 2000 | volume= 217 | issue= 3 | pages= 798-802 | pmid=11110946 | doi=10.1148/radiology.217.3.r00dc29798 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11110946  }}</ref>
*It is assumed that malignant adrenal lesions usually enhance rapidly but demonstrate a slower washout of contrast medium.<ref name="pmid9577483">{{cite journal| author=Szolar DH, Kammerhuber FH| title=Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. | journal=Radiology | year= 1998 | volume= 207 | issue= 2 | pages= 369-75 | pmid=9577483 | doi=10.1148/radiology.207.2.9577483 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9577483  }}</ref>
*It is assumed that [[malignant]] [[Adrenal gland|adrenal]] lesions usually enhance rapidly but demonstrate a slower washout of contrast medium.<ref name="pmid9577483">{{cite journal| author=Szolar DH, Kammerhuber FH| title=Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. | journal=Radiology | year= 1998 | volume= 207 | issue= 2 | pages= 369-75 | pmid=9577483 | doi=10.1148/radiology.207.2.9577483 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9577483  }}</ref>
* Fifteen minutes after administration of contrast, an absolute contrast medium washout of more than 40 percent was reported to be 100 percent sensitive and specific for adenoma when patients with adenomas were compared with carcinomas, pheochromocytomas, and metastases.<ref name="pmid25246052">{{cite journal| author=Song JH, Mayo-Smith WW| title=Current status of imaging for adrenal gland tumors. | journal=Surg Oncol Clin N Am | year= 2014 | volume= 23 | issue= 4 | pages= 847-61 | pmid=25246052 | doi=10.1016/j.soc.2014.06.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25246052  }}</ref>
* Fifteen minutes after administration of contrast, an absolute contrast medium washout of more than 40 percent was reported to be 100 percent sensitive and specific for adenoma when patients with adenomas were compared with [[carcinomas]], [[Pheochromocytoma|pheochromocytomas]], and [[metastases]].<ref name="pmid25246052">{{cite journal| author=Song JH, Mayo-Smith WW| title=Current status of imaging for adrenal gland tumors. | journal=Surg Oncol Clin N Am | year= 2014 | volume= 23 | issue= 4 | pages= 847-61 | pmid=25246052 | doi=10.1016/j.soc.2014.06.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25246052  }}</ref>
[[File:Incidentaloma.gif|left|300px|thumb|CT without contrast showing adrenal adenoma with HU less than 10, source: Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 26]]
[[File:Incidentaloma.gif|left|300px|thumb|CT without contrast showing adrenal adenoma with HU less than 10, source: Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 26]]
[[File:Angiomyolipoma.gif|left|300px|thumb|CT shows cortical mass fungating from the lower pole of the left kidney, predominantly of fat density, with areas of soft tissue component and prominent vascularity within. most ommonly angiomyolipoma, source: Case courtesy of Dr Abdallah Khateeb , Radiopaedia.org, rID: 44940]]
[[File:Angiomyolipoma.gif|left|300px|thumb|CT shows cortical mass fungating from the lower pole of the left kidney, predominantly of fat density, with areas of soft tissue component and prominent vascularity within. most ommonly angiomyolipoma, source: Case courtesy of Dr Abdallah Khateeb , Radiopaedia.org, rID: 44940]]

Revision as of 16:19, 28 August 2017

Incidentaloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Incidentaloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Incidentaloma CT scan On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Incidentaloma CT scan

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Incidentaloma CT scan

CDC on Incidentaloma CT scan

Incidentaloma CT scan in the news

Blogs on Incidentaloma CT scan

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Incidentaloma CT scan

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

[Location] CT scan may be helpful in the diagnosis of [disease name]. Differentiation between benign and malignant incidentaloma is important. Malignancy is suggested on CT by a large diameter more than 6 cms, irregular border, inhomogeneity, a “washout” of contrast after 15 min of less than 40%, and calcifications. Contrast-enhanced washout CT utilizes the unique perfusion pattern of adenomas. Adenomas take up intravenous CT contrast rapidly, but also have a rapid loss of contrast – a phenomenon termed ‘contrast enhancement washout’. It is assumed that malignant adrenal lesions usually enhance rapidly but demonstrate a slower washout of contrast medium.

CT scan

  • On CT scanning, differentiation between benign and malignant incidentaloma is important. Malignancy is suggested on CT by a large diameter more than 6 cms, irregular border, inhomogeneity, a “washout” of contrast after 15 min of less than 40%, and calcifications.[1]
  • However, many malignant lesions look benign. A large diameter is not diagnostic; only about 25% of masses larger than 4 cm were adrenal cancer.

The Hounsfield unit differentiation

  • CT has a high quantitative contrast resolution, which allows assessment of tissue density by measuring X-ray absorption of tissues.
  • This allows calculation of tissue attenuation or tissue density values, which are measured in Hounsfield units (HU).
  • The Hounsfield unit (HU) is a quantity commonly used in computed tomography (CT) scanning to express CT numbers in a standardized and convenient form.
  • Hounsfield units are obtained from a linear transformation of the measured attenuation coefficients.
  • The intracytoplasmic fat in adenomas results in low attenuation on nonenhanced CT in contrast to nonadenomas have higher attenuation in nonenhanced CT.[2]
  • Up to 30 percent of adenomas do not contain large amounts of lipid.
  • A homogeneous adrenal mass with a smooth border and an attenuation value <10 HU on unenhanced CT is likely to be a benign adenoma.[3]
  • The only patients in the nonadenoma groups with a noncontrast CT HU <10 were those with myelolipomas.

Contrast-enhanced washout CT

  • Contrast-enhanced washout CT utilizes the unique perfusion pattern of adenomas. Adenomas take up intravenous CT contrast rapidly, but also have a rapid loss of contrast – a phenomenon termed ‘contrast enhancement washout’.[4]
  • It is assumed that malignant adrenal lesions usually enhance rapidly but demonstrate a slower washout of contrast medium.[5]
  • Fifteen minutes after administration of contrast, an absolute contrast medium washout of more than 40 percent was reported to be 100 percent sensitive and specific for adenoma when patients with adenomas were compared with carcinomas, pheochromocytomas, and metastases.[6]
CT without contrast showing adrenal adenoma with HU less than 10, source: Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 26
CT shows cortical mass fungating from the lower pole of the left kidney, predominantly of fat density, with areas of soft tissue component and prominent vascularity within. most ommonly angiomyolipoma, source: Case courtesy of Dr Abdallah Khateeb , Radiopaedia.org, rID: 44940


References

  1. Boland GW, Blake MA, Hahn PF, Mayo-Smith WW (2008). "Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization". Radiology. 249 (3): 756–75. doi:10.1148/radiol.2493070976. PMID 19011181.
  2. Nieman LK (2010). "Approach to the patient with an adrenal incidentaloma". J Clin Endocrinol Metab. 95 (9): 4106–13. doi:10.1210/jc.2010-0457. PMC 2936073. PMID 20823463.
  3. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA; et al. (2003). "Management of the clinically inapparent adrenal mass ("incidentaloma")". Ann Intern Med. 138 (5): 424–9. PMID 12614096.
  4. Peña CS, Boland GW, Hahn PF, Lee MJ, Mueller PR (2000). "Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT". Radiology. 217 (3): 798–802. doi:10.1148/radiology.217.3.r00dc29798. PMID 11110946.
  5. Szolar DH, Kammerhuber FH (1998). "Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT". Radiology. 207 (2): 369–75. doi:10.1148/radiology.207.2.9577483. PMID 9577483.
  6. Song JH, Mayo-Smith WW (2014). "Current status of imaging for adrenal gland tumors". Surg Oncol Clin N Am. 23 (4): 847–61. doi:10.1016/j.soc.2014.06.002. PMID 25246052.

Template:WH Template:WS